FREE NEWSLETTER

GET EXCLUSIVE CONTENT

Free Newsletter Free Newsletter
reveal-banner-180px-x-150px-v1gif

Legal IT Newswire… ideaPoint Announces Integration of Clarivate Analytics’ Cortellis for Enhanced Competitive Insight

Added on the 25th Mar 2019 at 9:35 am
Share Button

Anaqua, a leading software provider of intellectual property and innovation management solutions, today announced that ideaPoint™ is now enhanced with the integration of content from CortellisTM, a suite of intelligence solutions provided by Clarivate Analytics. Cortellis is designed to unlock hidden insights to enable data-driven decision making across the R&D lifecycle. The integration brings Cortellis Competitive Intelligence to ideaPoint users, supporting faster, more accurate analysis of business development options.

Through this partnership, ideaPoint users can now enhance competitive insight. With a simple click, pharmaceutical and biotechnology companies can unlock the landscape of an opportunity to quickly understand white space or perform a high-level canvas to determine best candidates for Merger & Acquisition or Licensing opportunities. The addition of selected Cortellis content enables users to view comparator deals and discover areas of active partnering activity.

 

“At Anaqua, we are dedicated to delivering the most sophisticated intelligent data and analytics our clients can leverage to exponentially bring value to their business,” said Bob Romeo, CEO of Anaqua. “Integrating Cortellis content within ideaPoint further supports our efforts in making the biopharma industry a more collaborative, efficient space.”

 

“Organizations looking to get the most value out of their Partnering & Innovation Programs now have the opportunity to enhance their competitive insight by pairing market intelligence directly with a partnering opportunity,” said Scott Shaunessy, CEO of ideaPoint. “Partnerships with elite providers such as Clarivate Analytics demonstrate our commitment to making it easier for the biopharma industry to capitalize on partnering opportunities and increase success across the drug development lifecycle.”

There are no comments yet, add one below.

Any Comment?